I. Introduction
Endometriosis is a benign, estrogen-dependent, chronic gynecological disorder characterized by the presence of endometrial tissue outside the uterus. Lesions are usually located on dependent surfaces in the pelvis and most often affect the ovaries and cul-de-sac. They can also be found in other areas such as the abdominal viscera, the lungs, and the urinary tract. Endometriosis affects (6-10%) of women of reproductive age and is known to be associated with pelvic pain and infertility [1] .Endometriosis can be a recurrent disease, both after cessation of medical suppressive treatment and after surgical treatment. Recurrences of endometriosis after surgery can be explained by incomplete surgery, persistence and growth of microscopic endometriosis, the development of new lesions, or a combination of these factors. However, it is not known whether temporary and repeated exposure to high E 2 levels during controlled ovarian hyperstimulation (COH) for in vitrofertilization (IVF) contributes to the recurrence of endometriosis [2] .Medical treatment of endometriosis typically involves hormonal manipulation of the menstrual cycle to create an amenorrheic state, thus producing an environment unfavorable to endometrial tissue. Danazol, progestational drugs, gestrinone, oral contraceptives, and gonadotropin-releasing hormone (GnRH) agonists (GnRHa) are conventionally used medical agents. In addition, experimental medications, such as aromatase inhibitors, GnRH antagonists, pentoxifylline, tumor necrosis factor-α inhibitors, angiogenesis inhibitors, and matrix metalloproteinase inhibitors, hold the potential for greater efficacy and flexibility with fewer side effects [3] .GnRHaare one of the most widely used medical therapies for endometriosis. These agents induce medical menopause by down-regulating hypothalamic-pituitary GnRH receptors, thus causing decreased gonadotropin secretion, suppression of ovulation and reduced serum estrogen levels. Several GnRHa used for the treatment of endometriosis include nafarelin, buserelin, histrelin, triptorelin, leuprolide and goserlin acetate [4] .Goserelin acetate (trade name Zoladex) is a luteinizing hormone releasing hormone (LHRH) agonist ((LHRHa)). It is a synthetic analog of LHRH. LHRHainitially stimulate the release of LH, resulting in a transient elevation in serum estradiol in women. However, chronic administration can cause down-regulation of the LHRH receptors, thus inhibiting the secretion of LH and ultimately the sex hormones (androgen, estradiol).LHRHa reduce the ovarian secretion of estradiol and progesterone in women, leading to inhibition of estrogen-dependent cancers. Serum estradiol level is suppressed in women around 4 weeks after initiation of treatment. LHRHa are 50-100 times more potent than LHRH. In addition, they have a longer duration of action due to increased receptor affinity and greater biological stability [5] .Estrogens have been shown to have in vitro antioxidant effects on membrane phospholipid peroxidation [6] . The antioxidant activity of estrogens is associated with the phenol structure of estradiol and its metabolites [7] .Oxidative stress (OS) substances may have a contributive role in the pathogenesis of endometriosis through the activation of macrophages. These activated macrophages can aggravate oxidative stress conditions by the production of lipid peroxides and other by-products from reaction between apolipoproteins and peroxides [8] .Vivian et al showed thatproduction of reactive oxygen species (ROS) by peritoneal fluid mononuclear cellswas increased in endometriosis [9] .Oxidative damage occurs as a result of deficient antioxidant defensive mechanisms due to the effect of endogenous and exogenous factors. The aim of this study was to investigate the effect of goserlin acetate treatment on the hormonal changes, antioxidant status and oxidative stress (MDA) in goserelin acetatetreated patients with endometriosis and attempted to find the correlation between all these parameters with lipid peroxidation, given by MDA level's determination.
II. Materials and Methods
All chemical and reagents of analytical grade were purchased from Fluka unless indicated otherwise.
Subjects
Ninetywomen were participated in this study.Sixty womenpatients withendometriosis were undergoing laparoscopy and treated with goserlin acetate included as patients group (G1), age range was between25-46 years.The women patients were treated in Baghdad Teaching Hospital-Medical City and Kamal Al-Samarray Hospital, Baghdad, Iraq from January to July 2015.Thirty healthy women were selected as the control group (G2) age range was between 23-45 years. Thirty patients of women excluded, who were smoking and suffering from chronic or acute diseases such as hypertension, diabetes mellitus, diseases of the liver and kidney.
Anthropometric Measurements
Body mass index (BMI) was calculated as weight (kg) divided by the height 2 (m 2 ). Patients were taken as obese if their body mass index was 29.9 [10] . Waist:hip ratio (WHR) was calculated by dividing waist by hip measurements [11] .
Samples Analysis 2.3.1 Specimen collection
Fasting blood samples (10 mL) were collected and placed into containing tubes during 2-5 days of the menstrual cycle. After centrifugation at 1500×g for 10 min. the sera were removed and retained for assay of the level of vitamin C and all the parameters, respectively. Serum samples were stored at -80Cº until analysis.
Laboratory assessments
Serum concentration of (LH, FSH, Test.and E 2 )were measured by mini-VIDIS assay using kit supplied by Bio Merieux Sa-France. UAwas measured with an enzymatic colorimetric assay using a kit supplied by CromatestSpanish. CoQ 10 was measured with a competitive inhibition enzyme immunoassay technique using a kit supplied by HCUSABIO-China. The vitamins (A, E & β-carotene) were determined by a reverse-phase HPLC technique consisting of a Shimadzu-Japan binary solvent metering pump, a Rheodyne7125 injector with a 150L sample loop, column (25cm×4.6mm inner diameter), 5µm partical size, injection volume 50 µL and 10AV UV-Visible detector operatingat λ max 280 nm and 450 nm [12] [13] . Vitamin C determination is based on the oxidation of ascorbic acid in serum by Cu 2+ to form dehydroascorbic acid that react with the acidic 2,4-dinitrophenyl hydrazine to form a red bis-hydrazone which is measured as (A 520 nm) [14] . Malondialdehyde formed from the breakdown of poly unsaturated fatty acids serves as a convenient index of peroxidation reaction. The thiobarbituric acid method of [15] , was used to measure MDA.
Statistical analysis
All data were expressed as mean ± standard deviation (mean ± SD). Statistical analysis was performed using LSD, considering p < 0.05 as the lowest limit of significance. Statistical analysis was performed using a software program (SPSS 13 for Windows, USA). One-way analysis of variance (ANOVA) was used to compare means with least significant difference (LSD).
III.

Results
As Table1 recurrence of endometriosis was visualized in 60 casesincluded 4-6 months (70.0%) and 1-2 years (30.0%) period of illness, among the cases, (78.3%) were reported to have infertile status and (21.6%) had healthy state,cases were more likely to have ovarian stimulation drug (63.3%). Table2indicatesthe Table 3 displayed the lowest mean values of antioxidant vitamins (A, E, β-carotene, C and CoQ 10 ) and (E 2 as table2) levels were estimated in G1,(0.03±0.01mg/dL, 0.86±0.26 mg/dL, 0.09±0.01mg/dL, 1.12±0.41mg/dL, 33.04±9.83ng/mLand 33.94±5.82pg/mL) respectively,while the majority values estimate were in the G2 (0.04±0.0 mg/dL, 0.98±0.29mg/dL, 0.17±0.05mg/dL, 1.68±0.20mg/dL and 42.31±3.64ng/mL and 51.18±14.44pg/mL)respectively.The results from thisstudy revealed that (Test., UA and MDA) levels were highly significant increased (P ≤ 0.01), while a (BMI, W/H and LH/FSH) levels were significant increased (p<0.05). Vitamins (β-carotene, C and CoQ 10 ) and E 2 showed a highly significant decreased (p ≤ 0.001).However,a significant decreased (p<0.05) was noticed in vitamin Alevel.LH and FSHlevels were non significantincreased (p>0.05), whereasanon significantdecreased(p>0.05) of vitamin E levelin G1 compared with G2. Correlation is non significant at p>0.05, *Correlation is significant at p<0.05 level.
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IV. Discussion
Endometriosis is a common disease, defined as the presence of endometrial-like tissue outside the uterus, which induces a chronic, inflammatory reaction. While some women with endometriosis can experience painful symptoms and/or infertility, others have no symptoms at all. Susceptibility to endometriosis depends on a complex interaction of immunologic, genetic and hormonal factors [16] .Theoretically, the recurrent lesions might originate from either residual lesions or de novo cells coming through retrograde bleeding. For the former assumption, several studies demonstrate that the recurrence risk increases if the lesions are not completely removed at the initial surgery and they tend to arise on the same location [17] .Six months of GnRHa therapy immediately following surgery reduces the rate of symptom recurrence of endometriosis, and increases the length of time before symptoms recur. It is also more effective in managing endometriosis-related pain after surgery than using oral contraceptives in the same way [18] . In this study BMI was elevated significantly in group of treatment with goserelin as compared with control group, and this agreement with Alonso et al who found to have higher BMI and correlated with higher testosterone and lower total estradiol [19] . [20] Shown that BMI increases during treatment with GnRHa as a side effect.The body fat distribution, simply measured by the waist to hip girth, is supposedly a more important factor in predicting the risk of related diseases than the grade of obesity as determined by the BMI. [21] Revealed that greater waist to hip ratio is associated with risk of endometriosis. This finding supports the highly significant increase of W/H ratio in G1. Conventional medical treatment of endometriosis focuses on reducing estrogenstimulation, managing pain and preserving fertility. Hormone therapy is commonlyutilized because endometrial tissue responds to hormone stimulation.Estrogen has been shown to increase aberrantendometrial lesions, while progesterone and androgens maydecrease implant size [22] . Studies of the effects of testosterone derivative used in the treatment of endometriosis, menorrhagia, and endometrial hyperplasia, can contribute to the discussion of the effect of androgens on endometrial growth. In one study, women with endometrial hyperplasia received goserlin acetate and after this treatment, 82.8% showed a reversal of hyperplasia as assessed by clinical and histological examination. Furthermore, endometrial atrophy was detected in 65.8%, and amenorrhea in 90%. These findings support the biological capacity of goserlin acetate, a testosterone derivative, to reverse endometrial growth [23] .In the current study, it is found that an increased in Test levels in G2, due to the potential occurrence of testosterone surges on repeat injection of the goserelin acetate has also been investigated by [24] .Conversely, the highly significant decrease of estrogen in G2 compared with G1. Goserelinacetateis medicines that work by causing a temporary menopause. They are modified forms of GnRH that bind to receptors in the pituitary but have a longer half-life than native GnRH and thereby in down-regulation of the pituitary-ovarian axis and hyperestrogenism, The treatment causes the ovaries to stop producing estrogen, which causes the endometriosis implants to shrink [25] .Murphy et al whofound increased oxidation of low-density lipoprotein and increased concentrations of oxidized low-density lipoproteins in the peritoneal fluid in patients with pelvic endometriosis. Oxidative modification of these molecules involves peroxidation of the lipid component, which leads to release of aldehydes, such as malondialdeyde [26] . When oxidative stress was thought to be incriminated in endometriosis pathophysiology, antioxidants like vitamins (A, E, β-carotene, C and CoQ 10 ) were evaluated.Our result were in agreement with Szczepanskaet alwho reported that women with endometriosis had significantly lower levels of antioxidants than women without endometriosis, and significantly higher levels of lipid peroxides [27] .A study by [28] reported that serum CoQ 10 levels were higher among postmenopausal than among premenopausal women, suggesting that circulating steroid hormone or gonadotropin concentrations may influence plasma levels of CoQ 10 . For this reason, it is possible that we propose in this study that the effect of goserlin acetate was evident in the endometriotic patients that migratory rise Test hormone and lower level of estradiol that affects the level of CoQ 10 . Indeed, uric acid is the most abundant aqueous antioxidant, accounting for up to 60% of plasma antioxidative capacity. The antioxidative effect of uric acid is evidenced by its ability to directly scavenge free [29] .Jackson et al found that there was a positive association between oxidative stress and endometriosis [30] .In the current study, it is found the correlation between MDA and different variables measured in goserlin acetate-treated patients. These correlations were represented by a linear regression where the slope represents the direct effect of MDA on each variables level in patients, while the intercept represents the accumulative effect of other factors.A positive significant correlation between MDA and testosterone hormone in recurrent endometriotic patients.A negative correlation between E 2 and MDA. Our findings suggest that ovarian E 2 production may play an important antioxidant role, an inverse correlation between E 2 and lipid peroxide production with aging have been reported [31] .Whereas anegativecorrelation between MDA level and vitamins (A, E, UA and CoQ 10 ), suggesting a deficiency in these vitamins or its consumption as an antioxidant secondary to the excessive production of free radicals.
V. Conclusion
From all the aforementioned observations it can be concludedthat there is a significant and very effective role of goserlin acetate in alteration of the hormones changes and antioxidants status of women patients with endometriosis after the period of treatment.The results of this study showed the relationship between the variables that increase in the Test.levelsat the same timeE 2 levels displayed highly significant depletion in G1 patients compared with G2. In addition, the result of this study describes the effect of goserlin acetate by increasing the levels of oxidative stress and the low levels of antioxidant status.It is considered one of the most side effects of this treatment and prefers to choose other types of hormonal treatment to get a better result.
